Cmpx stock forecast.

Stock analysis for CompX International Inc (CIX:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Cmpx stock forecast. Things To Know About Cmpx stock forecast.

Stock Price Forecast. The 28 analysts offering 12-month price forecasts for APA Corp (US) have a median target of 48.50, with a high estimate of 65.00 and a low estimate of 34.00. The median ... Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.Stock Market Today: Stocks extend gains as investors ignore Powell warning on rates. Investors are heading into the final month of the year on solid footing, with an 18.5% gain for the S&P 500 and ...Meta Materials, Inc. engages in the manufacture and development of functional materials. Its technology platform enables global brands to deliver products to customers in consumer electronics, 5G ...

CMPX stock forecast Our latest prediction for Compass Therapeutics Inc's stock price was made on the March 15, 2023 when the stock price was at 3.56$. In the short term (2weeks), CMPX's stock price should underperform the market by -2.94%. During that period the price should oscillate between -8.72% and +5.46%. Nov 8, 2023 · Predictions of CMPX stock price for tomorrow.

NSD:CMPX Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes

2 days ago · Analyst Forecast. According to 4 analysts, the average rating for CMPX stock is "Strong Buy." The 12-month stock price forecast is $9.33, which is an increase of 452.07% from the latest price. Here’s how equities historically perform in the week after Thanksgiving as markets shift to holiday season. Nov. 27, 2023 at 12:40 p.m. ET by Christine Idzelis. Stock market barrels into year ...SOS Limited - ADR Stock Forecast, SOS stock price prediction. Price target in 14 days: 4.203 USD. The best long-term & short-term SOS Limited - ADR share price ...Compass Therapeutics, Inc. (CMPX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 1.6500 -0.0700 (-4.07%) At close: 04:00PM EST 1.6500 0.00 (0.00%) After hours: 04:20PM EST...

The value each CMPX share was expected to gain vs. the value that each CMPX share actually gained. Compass Therapeutics ( CMPX) reported Q2 2023 earnings per share (EPS) of -$0.09, missing estimates of -$0.08 by 9.30%. In the same quarter last year, Compass Therapeutics 's earnings per share (EPS) was -$0.08. Compass Therapeutics is expected to ...

CompX International, Inc. engages in the manufacturer of security products used in the recreational transportation, postal, office and institutional furniture, cabinetry, tool sto

Source: YCharts. Management said during the company's 2022 investor day in June last year that it expects long-term annual revenue growth of 20%. Assuming AMD's top line grows at an annual pace of ...27.27%. ABR. 1.38. Earnings ESP. More Info. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. The idea ...Dec 1, 2023 · The average twelve-month price prediction for Compass Therapeutics is $9.33 with a high price target of $10.30 and a low price target of $8.00. Learn more on CMPX's analyst rating history. Do Wall Street analysts like Compass Therapeutics more than its competitors? Learn more about Compass Therapeutics, Inc.'s (CMPX) dividend history, ex-dividend date, and yield. Zacks.com Our Research, Your SuccessCMPX Stock Forecast 2023. Compass Therapeutics boasts a robust drug pipeline, which explains why analysts are bullish on the stock. The Phase 2 and Phase 3 studies for cancer drug CTX-009 extend into H2 2023, at which time the company plans to initiate a Phase 1 study for its CTX-8371 drug also for cancer after filing an Investigational New Drug Application (IND) earlier in 2023.

Introducing Nasdaq Data Link - The Next Evolution in Data. The right insights, data and technology can create limitless possibilities. Nasdaq Data Link is a powerful, centralized, cloud-based ...Website. 2014. 26. Tom Schuetz. https://www.compasstherapeutics.com. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company’s product candidates include CTX-009, a bispecific antibody that blocks Delta …Apple Inc. Common Stock. $180.07 -0.12 -0.07%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs ...$10.50 (510.47% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Compass Therapeutics in the last 3 months. The average price target is $10.50 with a …PAYO Stock 12 Months Forecast. $8.80. (56.58% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Payoneer in the last 3 months. The average price target is $8.80 with a high forecast of $10.00 and a low forecast of $8.00. The average price target represents a 56.58% change from the last price of $5.62. The Compx International, Inc. - Class A stock forecast is 40.29786370896 USD for 2024 November 25, Monday; and 148.757 USD for 2028 November 25, Saturday with technical analysis. Compx International, Inc. - Class A (CIX) stock price prediction is 40.29786370896 USD.

In this article, we answer “what is sales forecasting?” by breaking down its objectives, owners, methods, and best practices. Sales | What is REVIEWED BY: Jess Pingrey Jess served on the founding team of a successful B2B startup and has use...

The above table shows the analyst CMPX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$1.77 The ALX Oncology Holdings Inc. stock price fell by -4.02% on the last day (Friday, 24th Nov 2023) from $9.21 to $8.84. During the last trading day the stock fluctuated 10.18% from a day low at $8.79 to a day high of $9.69. The price has risen in 6 of the last 10 days and is up by 12.76% over the past 2 weeks.Get the latest Cerner Corporation (CERN) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Stock Price Forecast. The 5 analysts offering 12-month price forecasts for CompoSecure Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 7.00. The median ...Previous Close $3.68. Volume 32.29K. Average Volume (3M) 157.25K. Market Cap. $1.22B. Enterprise Value $963.30M. Total Cash (Recent Filing) $259.49M. Total Debt (Recent Filing) $921.00K. Price to Earnings (P/E) -5.0.Dec 1, 2023 · 4 brokers have issued twelve-month target prices for Catalyst Pharmaceuticals' stock. Their CPRX share price targets range from $24.00 to $27.00. On average, they predict the company's stock price to reach $24.75 in the next twelve months. This suggests a possible upside of 67.0% from the stock's current price. Lastly, it’s important to evaluate a stock by comparing it against others in the same industry. Review the table below to see how Compass Therapeutics Inc. stock stands up against its competitors. Click into any of the below tickers to see their stock grades for value, momentum, quality and EPS revisions. Compass Therapeutics Inc. (CMPX ...Meta Materials, Inc. engages in the manufacture and development of functional materials. Its technology platform enables global brands to deliver products to customers in consumer electronics, 5G ...

CMPX stock forecast Our latest prediction for Compass Therapeutics Inc's stock price was made on the March 15, 2023 when the stock price was at 3.56$. In the short term (2weeks), CMPX's stock price should underperform the market by -2.94%. During that period the price should oscillate between -8.72% and +5.46%.

Compass Therapeutics Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of …

Analyst Forecast. According to 4 analysts, the average rating for CMPX stock is "Strong Buy." The 12-month stock price forecast is $9.33, which is an increase of 452.07% from the latest price.Milestone Pharmaceuticals (MIST) Stock Forecast, Price ...Find real-time CIX - CompX International Inc stock quotes, company profile, news and forecasts from CNN Business. GTHX Stock 12 Months Forecast. $9.00. (429.41% Upside) Based on 3 Wall Street analysts offering 12 month price targets for G1 Therapeutics in the last 3 months. The average price target is $9.00 with a high forecast of $9.00 and a low forecast of $9.00. The average price target represents a 429.41% change from the last price of $1.70.March 7, 2024. EPS forecast (this quarter) $0.30. Annual revenue (last year) $378.5M. Annual profit (last year) $18.7M. Net profit margin. Iterum Therapeutics plc. Analyst Report: Pfizer Inc. Pfizer is a leading developer and manufacturer of pharmaceuticals and biotech drugs. Its products include oncology and immunology drugs ...66.07%. Get the latest Compass Therapeutics Inc. (CMPX) real-time quote, historical performance, charts, and other financial information to help you make more informed …CMPX Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Biotechnology & Medical Research. Compass Therapeutics, Inc. (CMPX) Compare. Compass Therapeutics, Inc. 2.84 ...Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.

CMPX : 3.36 (+8.74%) Compass Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update Globe Newswire - Mon Mar 21, 2022. Ended 2021 with $144.5 million in cash and cash equivalentsCTX-009 (DLL4 X VEGF-A bispecific antibody) Global Phase 2 study in patients with advanced... Dec 1, 2023 · The average twelve-month price prediction for Compass Therapeutics is $9.33 with a high price target of $10.30 and a low price target of $8.00. Learn more on CMPX's analyst rating history. Do Wall Street analysts like Compass Therapeutics more than its competitors? As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial . Sign in to your free account to enjoy these benefits. In-depth …Instagram:https://instagram. phpusdfreedom otcbest uk forex broker1979 one dollar coins Stock Price Forecast. The 5 analysts offering 12-month price forecasts for CompoSecure Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 7.00. The median ... overstock platform bedbritish economy news If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...CPX Earnings Date and Information. Capital Power last announced its quarterly earnings results on November 1st, 2023. The reported C$2.26 EPS for the quarter, beating analysts' consensus estimates of C$1.37 by C$0.89. The company had revenue of C$1.15 billion for the quarter. Capital Power has generated C$4.40 earnings per share … investing for grandchild Dec 1, 2023 · The average twelve-month price prediction for Compass Therapeutics is $9.33 with a high price target of $10.30 and a low price target of $8.00. Learn more on CMPX's analyst rating history. Do Wall Street analysts like Compass Therapeutics more than its competitors? Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at data ...